Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Menon, S. Pandita, C. Kaur, R. Kaushik (New Delhi, India). Evaluation of oxidant-antioxidant status in different stages of COPD: determination of serum paraoxonase1 and malonyldialdehyde levels. Eur Respir J 2009; 34: Suppl. 53, 3153

Member's Comments

No comment yet.

Related content which might interest you: Relationship between peroxidation and antioxidant status in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Relationship between serum selenium levels, lipid peroxidation and acute bronchiolitis in infancy Source: Eur Respir J 2004; 24: Suppl. 48, 23s Year: 2004 Relations between serum lipid levels and inflammatory markers in obese asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Total serum bilirubin levels are not related to the severity of COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase1 activity in healthy people Source: Eur Respir J 2005; 26: Suppl. 49, 153s Year: 2005 Elevated serum levels of oxidative stress biomarkers in patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Serum TGF-β level in patients with different stages of stable COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003 Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Plasma total antioxidant status and erythrocyte antioxidant enzyme activities in lung cancer in Turkey Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Elevated serum levels of oxidized low-density lipoprotein in COPD patients Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Plasma acrolein level and myeloperoxidase gene polymorphism in COPD Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Measurement of serum total antioxidant status in patients with community acquired pneumonia: correlation with the severity of the disease Source: Eur Respir J 2002; 20: Suppl. 38, 283s Year: 2002 Relationship between blood eosinophil levels and severity of COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 The importance of erythrocyte superoxide dismutase activity and serum vitamin C concentration assay in children with asthma Source: Annual Congress 2006 - Aspects of childhood asthma Year: 2006 Assessment of plasma klotho concentration in stable COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016